Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 18 of 2663 for:    bilirubin

Hour-specific Transcutaneous Bilirubin in Healthy Term and Near-term Newborns of China

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03805165
Recruitment Status : Enrolling by invitation
First Posted : January 15, 2019
Last Update Posted : January 15, 2019
Sponsor:
Information provided by (Responsible Party):
yangjie, Guangdong Women and Children Hospital

Brief Summary:
Make a neonatal jaundiced nomogram on Chinese jaundice data by joinning the major neonate centers all around China.

Condition or disease
Jaundice, Neonatal

Detailed Description:
Jaundice in common amount Chinese newborn population. The neonatal jaundice guildline was made base on the AAP. guideline. Chinese newborn have their jaundice follow up and treatment plans make base on American neonatel jaundice data. Our group are now planning to have our own neonatel jaundice data by joinning the major neonate centers all around China. A neonatal jaundiced nomogram would be made base on Chinese neonatel jaundice data.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 3000 participants
Observational Model: Other
Time Perspective: Other
Official Title: Hour-specific Transcutaneous Bilirubin in Healthy Term and Near-term Newborns of China
Estimated Study Start Date : February 1, 2019
Estimated Primary Completion Date : March 31, 2019
Estimated Study Completion Date : December 31, 2019



Primary Outcome Measures :
  1. Hour-specific Transcutaneous Bilirubin Level [ Time Frame: 1 year ]
    make neonatal jaundiced nomogram base on the hour-specific transcutaneous bilirubin data



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 7 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Term and near term newborns, whos gestational age was more than 35 weeks(≥35)
Criteria

Inclusion Criteria:

gestational age more than 35 weeks(≥35) -

Exclusion Criteria:

all kinds of congenital diseases, infants with pathologic jaundice

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03805165


Locations
Layout table for location information
China, Guangdong
Jie Yang
Guangzhou, Guangdong, China, 511442
Sponsors and Collaborators
Guangdong Women and Children Hospital

Layout table for additonal information
Responsible Party: yangjie, Director of neonatology of GuangdongWCH, Guangdong Women and Children Hospital
ClinicalTrials.gov Identifier: NCT03805165     History of Changes
Other Study ID Numbers: Guangdong WCH
First Posted: January 15, 2019    Key Record Dates
Last Update Posted: January 15, 2019
Last Verified: January 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Bilirubin
Jaundice
Jaundice, Neonatal
Hyperbilirubinemia
Pathologic Processes
Skin Manifestations
Signs and Symptoms
Hyperbilirubinemia, Neonatal
Infant, Newborn, Diseases
Antioxidants
Molecular Mechanisms of Pharmacological Action
Protective Agents
Physiological Effects of Drugs